The use of selective estrogen receptor modulators and selective estrogen receptor down-regulators in breast cancer.
about
Antiestrogens: structure-activity relationships and use in breast cancer treatmentEstrogen-Related Receptors in Breast Cancer and Prostate CancerSystematic mapping of posttranslational modifications in human estrogen receptor-alpha with emphasis on novel phosphorylation sitesProtacs for treatment of cancer.Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4.Randomized controlled trial of toremifene 120 mg compared with exemestane 25 mg after prior treatment with a non-steroidal aromatase inhibitor in postmenopausal women with hormone receptor-positive metastatic breast cancerSoy intake in association with menopausal symptoms during the first 6 and 36 months after breast cancer diagnosis.Targeting Brn-3b in breast cancer therapy.Second-line treatment of postmenopausal women with advanced breast carcinoma.Intermolecular interactions identify ligand-selective activity of estrogen receptor alpha/beta dimers.A review of coumarin derivatives in pharmacotherapy of breast cancer.Estrogen Receptor Ligands: A Review (2013-2015).Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming.Effects of soy isoflavones on the concentration of hyaluronic acid in the vagina of type 1 diabetic rats.Flexible small molecular anti-estrogens with N,N-dialkylated-2,5-diethoxy-4-morpholinoaniline scaffold targets multiple estrogen receptor conformations.A Review of Fulvestrant in Breast Cancer.Efficacy of tamoxifen for the treatment of severe equine asthma
P2860
Q28077245-24068A0B-1A87-4796-A698-0A3CCA8119D5Q28084030-FDC2E7FC-4B67-44F8-8120-1712568D06EBQ33382611-E63DF244-423D-4499-A2FB-0A1CB8E239FAQ33896048-422707D2-54AB-4C7B-8DD9-2CC808CC7819Q34479551-8A7D65B3-B572-4BD3-9D8F-7E064C49E0D9Q34725685-8F0E94D1-9CEB-4FCE-966E-973E14419582Q34970602-EB4D711C-A175-457F-AC04-6D22160A2546Q36379362-BB38142C-9A4D-42DE-B3B0-205A443E9EA7Q36448699-4DB75027-0C71-46DE-B263-CCFBCF1E120AQ36999937-8D2259C3-89CC-4DF2-965F-3A850900C362Q37169601-8AD11723-1877-4CC6-B93A-51BCF810D7FDQ37339491-278E32C7-98FA-47BE-9130-46CAF6D24E4EQ47263046-8A46648F-1B2C-4273-9F56-0E66088504ECQ47652633-93D9C90E-5BC2-43B1-98A9-B83D271B82F8Q48100910-6D2928B5-57A7-4860-9DC6-3E7C726C2841Q53733893-9586C496-E5C4-4E3F-A376-DF806387C6A9Q58796490-2E05BB51-8FA7-488F-A9ED-1CCC97899C89
P2860
The use of selective estrogen receptor modulators and selective estrogen receptor down-regulators in breast cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The use of selective estrogen ...... n-regulators in breast cancer.
@ast
The use of selective estrogen ...... n-regulators in breast cancer.
@en
type
label
The use of selective estrogen ...... n-regulators in breast cancer.
@ast
The use of selective estrogen ...... n-regulators in breast cancer.
@en
prefLabel
The use of selective estrogen ...... n-regulators in breast cancer.
@ast
The use of selective estrogen ...... n-regulators in breast cancer.
@en
P2093
P1476
The use of selective estrogen ...... n-regulators in breast cancer.
@en
P2093
Anthony Howell
Sacha J Howell
Stephen R D Johnston
P356
10.1016/J.BEEM.2003.08.002
P577
2004-03-01T00:00:00Z